Program Leaders The Center organizes its cancer research into nine established scientific research programs that span the basic, clinical, translational, and population sciences: Cancer Cell Biology. Immunology, Molecular Therapeutics. Virology. Cancer Genetics, Clinical Research, Breast Cancer, Cancer Prevention and Control, and Cancer Epidemiology. Each program is led by outstanding researchers. With one exception, each program has 0.10 FTE devoted to its leadership. The exception is Clinical Research, the Center's largest program, which has 0.15 FTE. Five programs have single leaders;four have Program Co-Leaders. Program Leader responsibilities include: advising the Director on the Center's continued scientific and intellectual development and strategic planning;developing and promoting individual and collaborative research projects, advising and mentoring program members;organizing retreats, meetings. interest groups, and seminars;promoting interactions and collaboration both inside and outside the program;and advising the Director on Center operation. To meet these responsibilities. Program Leaders interact both formally (program meetings. retreats, etc) and informally with each other, program members, and other Center members. Program Leaders also interact both formally and informally with Senior Leaders. Formal interactions include the Program Planning Committee, retreats, core facility reviews, and individual/small group meetings with the Director. Informal interactions include individual meetings, faculty meetings, seminars, symposia, and committee meetings. Program Leaders meet with the Scientific Advisory Board and ad hoc consultants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-38
Application #
8594113
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$232,817
Indirect Cost
$66,182
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Guseman, Alex J; Perez Goncalves, Gerardo M; Speer, Shannon L et al. (2018) Protein shape modulates crowding effects. Proc Natl Acad Sci U S A 115:10965-10970
Xu, Bowen; Cai, Ling; Butler, Jason M et al. (2018) The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells. Stem Cell Reports 10:675-683
Gartlan, Kate H; Bommiasamy, Hemamalini; Paz, Katelyn et al. (2018) A critical role for donor-derived IL-22 in cutaneous chronic GVHD. Am J Transplant 18:810-820
Zhang, Yugen; Dittmer, Dirk P; Mieczkowski, Piotr A et al. (2018) RIG-I Detects Kaposi's Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner. MBio 9:
Abida, Wassim; Sawyers, Charles L (2018) Targeting DNA Repair in Prostate Cancer. J Clin Oncol 36:1017-1019
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
Liu, Jianfang; Lichtenberg, Tara; Hoadley, Katherine A et al. (2018) An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173:400-416.e11
Song, Lixin; Dunlap, Kaitlyn L; Tan, Xianming et al. (2018) Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study. JMIR Res Protoc 7:e51
Zhu, Cheng; Beck, Matthew V; Griffith, Jack D et al. (2018) Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 115:4661-4665
Weiser, Matthew; Simon, Jeremy M; Kochar, Bharati et al. (2018) Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut 67:36-42

Showing the most recent 10 out of 1525 publications